Effect of angiotensin receptor neprilysin inhibitors on left atrial remodeling and prognosis in heart failure

AIMS: The angiotensin receptor–neprilysin inhibitor (ARNI), sacubitril/valsartan, confers additional protective effects compared with angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers (ACEIs/ARBs) in terms of reversed left ventricular (LV) remodelling and improves the prognos...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yuxi, Song, Shuang, Zhang, Yanli, Mo, Wenqiong, Zhang, Xinxin, Wang, Ning, Xia, Yunlong, Tse, Gary, Liu, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787963/
https://www.ncbi.nlm.nih.gov/pubmed/34779134
http://dx.doi.org/10.1002/ehf2.13691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787963/
https://www.ncbi.nlm.nih.gov/pubmed/34779134
http://dx.doi.org/10.1002/ehf2.13691

Ejemplares similares